|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Hythiam, Inc. Announces Publication on Predictive Modeling for Substance Dependent Populations in Perspectives in Health Information Management
1/13/2010 9:34:27 AM
LOS ANGELES--(BUSINESS WIRE)--Hythiam, Inc. (NASDAQ:HYTM) announced today the publication of a paper titled, “Application of Multivariate Probabilistic (Bayesian) Networks to Substance use Disorder Risk Stratification and Cost Estimation,” Weinstein L., Radano T., et. al., Perspectives in Health Information Management, Volume 6, Fall 2009. The predictive modeling work that forms the basis for the publication was sponsored by Hythiam to develop advanced tools for use in its Catasys program. The paper, co-authored by Lawrence Weinstein, MD and Hythiam’s Senior Vice President of Medical Affairs, features the creation of predictive models that draw on historic healthcare claims and diagnostic data to estimate the expected future costs of a population with a substance dependence diagnosis, and that can stratify the population based on the expected benefit of intervention. Thus, the predictive models can be utilized as the basis for Hythiam to develop new and innovative approaches for substance dependence solutions that result in improved member care and reduced costs for payors.
|
|
|
|
|
|
|
|
|
|
|